News Website

Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Repare Therapeutics eyes Phase III cancer study after Mythic trial success Yahoo Finance

Published: Dec. 13, 2024, 3:28 p.m.

Read Full Article

Beware ‘toasted skin syndrome,’ a dangerous and sometimes permanent side effect of using a heating pad - MSN

Beware ‘toasted skin syndrome,’ a dangerous and sometimes permanent side effect of using a heating pad MSN

Published: Dec. 13, 2024, 1:58 p.m.

Read Full Article

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial CRISPR Medicine News

Published: Dec. 13, 2024, 12:56 p.m.

Read Full Article

Bindi Irwin shares new ‘devastating’ health detail - Newsner

Bindi Irwin shares new ‘devastating’ health detail Newsner

Published: Dec. 13, 2024, 11:41 a.m.

Read Full Article

Exposure locations revealed as major city on alert for contagious disease - Head Topics

Exposure locations revealed as major city on alert for contagious disease Head Topics

Published: Dec. 13, 2024, 1:09 a.m.

Read Full Article

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian - Digital More

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Digital More

Published: Dec. 13, 2024, 12:45 a.m.

Read Full Article

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong - The Manila Times

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong The Manila Times

Published: Dec. 13, 2024, 12:27 a.m.

Read Full Article

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial BioSpace

Published: Dec. 12, 2024, 11:25 p.m.

Read Full Article

Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis - Seeking Alpha

Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis Seeking Alpha

Published: Dec. 12, 2024, 8:25 p.m.

Read Full Article

Almost one in five women avoid their GP as they fear they won't be taken seriously - Rotherham Advertiser

Almost one in five women avoid their GP as they fear they won't be taken seriously Rotherham Advertiser

Published: Dec. 12, 2024, 5:10 p.m.

Read Full Article

Latest Articles

Repare Therapeutics eyes Phase III cancer study after Mythic trial success - Yahoo Finance

Beware ‘toasted skin syndrome,’ a dangerous and sometimes permanent side effect of using a heating pad - MSN

Press Release Service: Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - CRISPR Medicine News

Bindi Irwin shares new ‘devastating’ health detail - Newsner

Exposure locations revealed as major city on alert for contagious disease - Head Topics

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian - Digital More

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong - The Manila Times

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis - Seeking Alpha

Almost one in five women avoid their GP as they fear they won't be taken seriously - Rotherham Advertiser

Subscribe to Our Newsletter